Illumina Ventures Closes $230 Million Fund

Genomics-focused fund will support breakthroughs in life science research, clinical diagnostics, novel therapeutic platforms, and other technologies impacting human health SAN FRANCISCO, Oct. 16, 2017 -- (Healthcare Sales & Marketing Network) -- Illumi... Biopharmaceuticals, Personalized Medicine, Venture Capital Illumina Ventures, genomics, precision medicine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news